Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hemmer

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysisM Vergelli, B Hemmer, P A Muraro, et al.
Neurology|April 6, 2011
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MSM C Kowarik, H L Pellkofer, S Cepok, et al.
Plos One|July 28, 2020
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumabC L Kemmerer, V Pernpeintner, C Ruschil, et al.
Journal of Neurology|May 15, 2016
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensityA Beer, V Biberacher, P Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2010
Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosisA Chan, B F Decard, C Franke, et al.
European Journal of Neurology|April 24, 2010
Patent foramen ovale is not associated with an increased risk of stroke recurrenceR Feurer, S Sadikovic, D Sepp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cellsM Vergelli, B Hemmer, M Kalbus, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 25, 2021
Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing-Remitting Multiple SclerosisS Grahl, M Bussas, B Wiestler, et al.
International Immunology|March 4, 2000
Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survivalB Hemmer, T Kondo, B Gran, et al.
Journal of Immunological Methods|December 21, 2000
Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysisP A Muraro, M Jacobsen, A Necker, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysisM Vergelli, B Hemmer, P A Muraro, et al.
Neurology|April 6, 2011
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MSM C Kowarik, H L Pellkofer, S Cepok, et al.
Plos One|July 28, 2020
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumabC L Kemmerer, V Pernpeintner, C Ruschil, et al.
Journal of Neurology|May 15, 2016
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensityA Beer, V Biberacher, P Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2010
Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosisA Chan, B F Decard, C Franke, et al.
European Journal of Neurology|April 24, 2010
Patent foramen ovale is not associated with an increased risk of stroke recurrenceR Feurer, S Sadikovic, D Sepp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cellsM Vergelli, B Hemmer, M Kalbus, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 25, 2021
Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing-Remitting Multiple SclerosisS Grahl, M Bussas, B Wiestler, et al.
International Immunology|March 4, 2000
Minimal peptide length requirements for CD4(+) T cell clones--implications for molecular mimicry and T cell survivalB Hemmer, T Kondo, B Gran, et al.
Journal of Immunological Methods|December 21, 2000
Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysisP A Muraro, M Jacobsen, A Necker, et al.
Pageof 14